ACRX - AcelRx Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts7777
Avg. Estimate-0.22-0.23-0.85-0.66
Low Estimate-0.25-0.26-0.93-0.84
High Estimate-0.2-0.21-0.79-0.47
Year Ago EPS-0.2-0.21-0.81-0.85
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts8888
Avg. Estimate1.1M1.99M6.48M30.22M
Low Estimate450k800k2.73M19.43M
High Estimate3.5M3.7M12M47.2M
Year Ago Sales818k377k2.15M6.48M
Sales Growth (year/est)34.50%427.90%201.30%366.40%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.2-0.21-0.2-0.22
EPS Actual-0.2-0.21-0.18-0.17
Difference000.020.05
Surprise %0.00%0.00%10.00%22.70%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.22-0.23-0.85-0.66
7 Days Ago-0.22-0.23-0.85-0.66
30 Days Ago-0.22-0.23-0.85-0.66
60 Days Ago-0.22-0.23-0.85-0.66
90 Days Ago-0.22-0.23-0.91-0.68
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days1N/A1N/A
Up Last 30 Days1N/A1N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/A1N/A1
Growth EstimatesACRXIndustrySectorS&P 500
Current Qtr.-10.00%N/AN/A0.00
Next Qtr.-9.50%N/AN/A0.03
Current Year-4.90%N/AN/A0.04
Next Year22.40%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A